New Zealand markets closed

Alnylam Pharmaceuticals, Inc. (ALNY)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
198.61-5.72 (-2.80%)
At close: 4:00PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts17171918
Avg. Estimate-1.57-1.59-6.35-4.07
Low estimate-2.01-2.49-7.82-6.65
High estimate-1.25-0.85-5.16-1.69
Year ago EPS-2.18-2.09-7.46-6.35
Revenue estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts17172119
Avg. Estimate218.69M239.28M853.11M1.29B
Low estimate202.06M214.4M823.6M1.1B
High estimate240.1M263.8M902M1.5B
Year ago sales125.85M163.56M492.85M853.11M
Sales growth (year/est)73.80%46.30%73.10%50.60%
Earnings history29/09/202030/12/202030/03/202129/06/2021
Est. EPS-1.64-1.71-1.73-1.61
Actual EPS-2.18-2.09-1.71-1.61
Difference-0.54-0.380.020
Surprise %-32.90%-22.20%1.20%0.00%
EPS trendCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Current estimate-1.57-1.59-6.35-4.07
7 days ago-1.57-1.59-6.35-4.1
30 days ago-1.57-1.59-6.35-3.76
60 days ago-1.57-1.58-6.4-3.75
90 days ago-1.57-1.45-6.37-3.6
EPS revisionsCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Up last 7 days1N/AN/A1
Up last 30 days1N/AN/A1
Down last 7 daysN/AN/AN/AN/A
Down last 30 days1221
Growth estimatesALNYIndustrySector(s)S&P 500
Current qtr.28.00%N/AN/AN/A
Next qtr.23.90%N/AN/AN/A
Current year14.90%N/AN/AN/A
Next year35.90%N/AN/AN/A
Next 5 years (per annum)7.86%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A